By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

European Medicines Agency (EMA) 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a


SEARCH JOBS


Industry
Services






Company News
Lysogene Receives Orphan Drug Designation From EMA For LYS-GM101 For Treatment Of GM1 Gangliosidosis 2/21/2017 10:15:19 AM
Armetheon Announces EMA's Support For 1000 Patient Single Phase lll Study Prior To MAA Filing For Its Novel Oral Anticoagulant Tecarfarin 2/14/2017 7:00:16 AM
VBI Vaccines Receives Positive EMA Scientific Advice Regarding Sci-B-Vac Phase III Clinical Study 2/7/2017 8:07:52 AM
Ariad (ARIA) Announces Submission Of Marketing Authorization Application For Brigatinib To EMA 2/6/2017 6:34:01 AM
BioMarin (BMRN) Receives Access To Priority Medicines (PRIME) Regulatory Support From EMA For BMN 270 Gene Therapy In Hemophilia A 2/2/2017 6:55:53 AM
Biocryst (BCRX) Announces The Acceptance Of Peramivir MAA Filing By The EMA 1/30/2017 7:51:12 AM
Enanta Pharmaceuticals, Inc. Release: Pharma Announces EMA Grants Accelerated Assessment, Validates Marketing Authorization Application For AbbVie (ABBV)’s Investigational HCV Regimen Of Glecaprevir/Pibrentasvir (G/P) For The Treatment Of All Major Genotypes (GT1-6) Of Chronic Hepatitis C 1/24/2017 8:19:29 AM
AbbVie (ABBV) Release: EMA Grants Accelerated Assessment, Validates Marketing Authorization Application For Pharma's Investigational Regimen Of Glecaprevir/Pibrentasvir (G/P) For The Treatment Of Chronic Hepatitis C In All Major Genotypes (GT1-6) 1/24/2017 7:17:57 AM
Kamada Ltd. (KMDA) Release: Company Announces Positive Scientific Advice Response From The EMA Focused On Alpha-1 Antitrypsin IV For Treatment Of Acute Graft-Versus-Host Disease 1/23/2017 7:09:35 AM
Novelion (AEGR) Release: Biotech Announces Acceptance Of Marketing Authorization Application For Metreleptin By EMA 1/23/2017 6:52:24 AM
12345678910...
//-->